Meta-Analysis Appraising High Clopidogrel Loading in Patients Undergoing Percutaneous Coronary Intervention†
- 1 October 2007
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 100 (8) , 1199-1206
- https://doi.org/10.1016/j.amjcard.2007.05.048
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Benefits of clopidogrel in patients undergoing coronary stenting significantly depend on loading dose: Evidence from a meta-regressionAmerican Heart Journal, 2007
- Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary StentingJournal of the American College of Cardiology, 2006
- Clopidogrel Loading Dose (300 Versus 600 mg) Strategies for Patients With Stable Angina Pectoris Subjected to Percutaneous Coronary InterventionThe American Journal of Cardiology, 2006
- Optimal Timing for the Initiation of Pre-Treatment With 300 mg Clopidogrel Before Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2006
- Comparison of Two Methods to Detect Publication Bias in Meta-analysisJAMA, 2006
- Absorption, Metabolization, and Antiplatelet Effects of 300-, 600-, and 900-mg Loading Doses of ClopidogrelCirculation, 2005
- Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary InterventionCirculation, 2005
- Long-term benefits of an early invasive management in acute coronary syndromes depend on intracoronary stenting and aggressive antiplatelet treatment: A metaregressionAmerican Heart Journal, 2005
- Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of PlateletsCirculation, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003